AbCellera’s Billionaire CEO Says New Covid Treatment Could Be A ‘Game Changer’ As Global Cases Rise The company’s new antibody treatment, which is heading to clinical trials, works against variants and may be potent enough to be used in areas without a strong medical infrastructure.